Polaris has been working in the nutritional lipid area for about 15 years and said the acquisition provided it with added innovation potential in marine ingredients for use in, “nutraceutics, food and cosmetics”.
In particular, Ocean Nutrasciences has done a lot of work taking extracts from Northern shrimp which have been found to be high in astaxanthine, amino acids and omega-3 forms EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
In a statement Polaris said Ocean Nutrasciences, “develops, makes, values (via clinical studies) and markets marine ingredients (shellfish, algae and fish) exempt from organic solvents”.
The company had a strong, “expertise in the development of biochemical processes and state-of-the-art equipments” and its Quebec location gave it access to, “an optimal volume of strictly controlled fresh raw materials”.
The company was not available for further comment at the time of publication.
Polaris has had a partnership with leading omega-3 supplier EPAX that sees it distributing its oils in France, Spain and Portugal.
It is also a member of GOED (The Global Organization for EPA and DHA Omega-3s).
The company will be exhibiting at the International Nutraceutical, Cosmeceutical, ‘Functional Foods & Drinks’ and ‘Health’ Ingredients Trade Exhibition in Milan between October 26 and 28.
Polaris employs a patented technology called Qualitysilver that stabilises marine or vegetable-origin polyunsaturated oils.